Clinical trial with a beta-receptor antagonist (propranolol) in parkinsonism.
D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D010300:Parkinson Disease / Q000188:drug therapy*; D011379:Prognosis; D011433:Propranolol; D013223:Statistics as Topic; D013565:Sympatholytics / Q000627:therapeutic use*
D013565:Sympatholytics; D011433:Propranolol
Lancet. 1964 Oct 24;2(7365):892
14197192